Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1128/CMR.00074-16 http://scihub22266oqcxt.onion/10.1128/CMR.00074-16 C5355639!5355639!28298471     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Microbiol+Rev 2017 ; 30 (2): 503-28 Nephropedia Template TP {{tp|p=28298471|t=2017. BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies |pdf=|usr=}}{{28298471}} gab.com Text BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies JO: Clin Microbiol Rev http://www.kidney.de/pget.php?&tw=1&pmid=28298471 #FOAvip BK polyomavirus (BKV) causes frequent infections during childhood and establishes persistent infections within renal tubular cells and the uroepithelium, with minimal clinical implications. However, reactivation of BKV in immunocompromised individuals following renal or hematopoietic stem cell transplantation may cause serious complications, including BKV-associated nephropathy (BKVAN), ureteric stenosis, or hemorrhagic cystitis. Implementation of more potent immunosuppression and increased posttransplant surveillance has resulted in a higher incidence of BKVAN. Antiviral immunity plays a crucial role in controlling BKV replication, and our increasing knowledge about host-virus interactions has led to the development of improved diagnostic tools and clinical management strategies. Currently, there are no effective antiviral agents for BKV infection, and the mainstay of managing reactivation is reduction of immunosuppression. Development of immune-based therapies to combat BKV may provide new and exciting opportunities for the successful treatment of BKV-associated complications. Twit Text FOAVip BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies ????Clin Microbiol Rev http://www.kidney.de/pget.php?&tw=1&pmid=28298471 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28298471 #FOAvip English Wikipedia <ref>{{Cite pmid|28298471}}</ref> BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies #MMPMID28298471 Ambalathingal GR; Francis RS; Smyth MJ; Smith C; Khanna R Clin Microbiol Rev 2017[Apr]; 30 (2): 503-28 PMID28298471show ga BK polyomavirus (BKV) causes frequent infections during childhood and establishes persistent infections within renal tubular cells and the uroepithelium, with minimal clinical implications. However, reactivation of BKV in immunocompromised individuals following renal or hematopoietic stem cell transplantation may cause serious complications, including BKV-associated nephropathy (BKVAN), ureteric stenosis, or hemorrhagic cystitis. Implementation of more potent immunosuppression and increased posttransplant surveillance has resulted in a higher incidence of BKVAN. Antiviral immunity plays a crucial role in controlling BKV replication, and our increasing knowledge about host-virus interactions has led to the development of improved diagnostic tools and clinical management strategies. Currently, there are no effective antiviral agents for BKV infection, and the mainstay of managing reactivation is reduction of immunosuppression. Development of immune-based therapies to combat BKV may provide new and exciting opportunities for the successful treatment of BKV-associated complications. äBK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging The(epmc).pdf DeepDyve Pubget Overpricing